Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (29442) 29442
Publication (2102) 2102
Book Chapter (495) 495
Book Review (360) 360
Dissertation (151) 151
Conference Proceeding (129) 129
Book / eBook (107) 107
Magazine Article (41) 41
Web Resource (19) 19
Journal / eJournal (14) 14
Paper (9) 9
Trade Publication Article (8) 8
Government Document (7) 7
Data Set (5) 5
Reference (2) 2
Newspaper Article (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16117) 16117
female (9974) 9974
index medicus (9940) 9940
male (8573) 8573
adult (6361) 6361
middle aged (5750) 5750
atypical antipsychotics (5126) 5126
psychiatry (4835) 4835
schizophrenia (3987) 3987
aged (3973) 3973
pharmacology & pharmacy (3343) 3343
neurosciences (3120) 3120
animals (2946) 2946
clinical neurology (2839) 2839
pathology (2582) 2582
antipsychotic agents - therapeutic use (2528) 2528
adolescent (2383) 2383
diagnosis (2376) 2376
oncology (2135) 2135
antipsychotic agents - adverse effects (1868) 1868
treatment outcome (1832) 1832
schizophrenia - drug therapy (1815) 1815
cancer (1753) 1753
olanzapine (1749) 1749
child (1701) 1701
retrospective studies (1669) 1669
analysis (1619) 1619
aged, 80 and over (1611) 1611
risk factors (1559) 1559
surgery (1549) 1549
risperidone (1542) 1542
diagnosis, differential (1519) 1519
double-blind (1511) 1511
clozapine (1491) 1491
young adult (1454) 1454
medicine & public health (1367) 1367
atypical (1303) 1303
research (1299) 1299
care and treatment (1229) 1229
children (1191) 1191
risk (1176) 1176
rats (1157) 1157
immunohistochemistry (1141) 1141
haloperidol (1099) 1099
health aspects (1084) 1084
antipsychotic drugs (1056) 1056
prevalence (1046) 1046
management (1044) 1044
child, preschool (1041) 1041
prognosis (1001) 1001
pediatrics (991) 991
antipsychotic agents - pharmacology (985) 985
follow-up studies (948) 948
tumors (936) 936
article (929) 929
bipolar disorder (909) 909
biopsy (888) 888
atypical antipsychotic-drugs (885) 885
medicine, general & internal (881) 881
drug therapy (878) 878
antipsychotics (876) 876
women (869) 869
carcinoma (839) 839
disease (835) 835
drugs (820) 820
infant (814) 814
obstetrics & gynecology (789) 789
time factors (768) 768
mutation (763) 763
dermatology (761) 761
antipsychotic agents - administration & dosage (754) 754
expression (746) 746
magnetic resonance imaging (741) 741
dose-response relationship, drug (728) 728
atypical antipsychotic (725) 725
follow-up (723) 723
atypical mycobacteria (719) 719
cell biology (719) 719
atypical depression (712) 712
biochemistry & molecular biology (706) 706
efficacy (702) 702
dopamine (685) 685
lesions (685) 685
quetiapine (671) 671
mice (661) 661
atypical ductal hyperplasia (649) 649
brain (649) 649
depression (648) 648
neurology (646) 646
psychiatric status rating scales (645) 645
abridged index medicus (630) 630
psychotropic drugs (626) 626
case report (605) 605
adenocarcinoma (594) 594
breast neoplasms - pathology (591) 591
immunology (590) 590
sensitivity and specificity (587) 587
aripiprazole (577) 577
atypical adenomatous hyperplasia (573) 573
medicine (573) 573
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (31) 31
OISE - Stacks (30) 30
Robarts - Stacks (21) 21
Gerstein Science - Stacks (16) 16
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
UofT at Mississauga - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Holland Bloorview Kids Rehabilitation - Stacks (3) 3
UofT at Scarborough - Stacks (3) 3
OISE - Curriculum Resources (2) 2
OISE - Periodical Stacks (2) 2
OISE - Storage (2) 2
Online Resources - Online (2) 2
Engineering & Comp. Sci. - Stacks (1) 1
Knox College (Caven) - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
OISE - Lost (1) 1
OISE - May be requested in 6-10 wks (1) 1
OISE - Reference (1) 1
Scarborough Hospital - General (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Mississauga - Reference (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (26721) 26721
German (800) 800
French (705) 705
Spanish (545) 545
Japanese (316) 316
Korean (286) 286
Italian (143) 143
Polish (124) 124
Russian (123) 123
Chinese (120) 120
Turkish (119) 119
Portuguese (107) 107
Czech (77) 77
Dutch (27) 27
Croatian (20) 20
Hungarian (20) 20
Slovak (14) 14
Persian (8) 8
Serbian (5) 5
Swedish (5) 5
Icelandic (4) 4
Slovenian (4) 4
Danish (3) 3
Bosnian (2) 2
Norwegian (2) 2
Romanian (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Expert Statements on the Standard of Care in Critically Ill Adult Patients With Atypical Hemolytic Uremic Syndrome
by Azoulay, Elie and Knoebl, Paul and Garnacho-Montero, José and Rusinova, Katerina and Galstian, Gennadii and Eggimann, Philippe and Abroug, Fekri and Benoit, Dominique and von Bergwelt-Baildon, Michael and Wendon, Julia and Scully, Marie
Chest, ISSN 0012-3692, 08/2017, Volume 152, Issue 2, pp. 424 - 434
A typical hemolytic uremic syndrome (aHUS) presents similarly to thrombotic thrombocytopenic purpura (TTP) and other causes or conditions with thrombotic... 
atypical hemolytic uremic syndrome | intensive care | thrombocytopenia | organ failure | eculizumab | thrombotic microangiopathy | plasma exchange | ACTIVATION | MANAGEMENT | COMPLEMENT INHIBITOR ECULIZUMAB | THROMBOTIC THROMBOCYTOPENIC PURPURA | I TREAT | MICROANGIOPATHIES | CONSENSUS DOCUMENT | RESPIRATORY SYSTEM | UPDATE | AHUS | SYNDROME DIAGNOSIS | CRITICAL CARE MEDICINE | Diagnosis, Differential | Atypical Hemolytic Uremic Syndrome - therapy | Critical Care - standards | Standard of Care | Humans | Atypical Hemolytic Uremic Syndrome - etiology | Genetic Testing - methods | ADAMTS13 Protein - metabolism | Complement System Proteins - metabolism | Plasma Exchange - methods | Adult | Atypical Hemolytic Uremic Syndrome - diagnosis | Quality of Health Care - standards | Intensive care units | Services | Physiology, Pathological | Care and treatment | Usage | Critically ill | Diagnosis | Health aspects | Hemolytic-uremic syndrome
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Discontinuation of Eculizumab Maintenance Treatment for Atypical Hemolytic Uremic Syndrome: A Report of 10 Cases
by Ardissino, Gianluigi, MD, PhD and Testa, Sara, MD and Possenti, Ilaria, MD and Tel, Francesca, MD and Paglialonga, Fabio, MD and Salardi, Stefania, BS and Tedeschi, Silvana, MD and Belingheri, Mirco, MD and Cugno, Massimo, MD
American Journal of Kidney Diseases, ISSN 0272-6386, 2014, Volume 64, Issue 4, pp. 633 - 637
Atypical hemolytic uremic syndrome (aHUS) is a life-threatening thrombotic microangiopathy, and as many as 70% of patients with aHUS have mutations in the... 
Nephrology | Atypical hemolytic uremic syndrome | discontinuation | eculizumab | AUTOANTIBODIES | COMPLEMENT INHIBITOR ECULIZUMAB | HUS | CFI | UROLOGY & NEPHROLOGY | MUTATIONS | Atypical Hemolytic Uremic Syndrome - economics | Recurrence | Drug-Related Side Effects and Adverse Reactions - prevention & control | Humans | Middle Aged | Child, Preschool | Cost of Illness | Infant | Male | Atypical Hemolytic Uremic Syndrome - psychology | Antibodies, Monoclonal, Humanized - economics | Antibodies, Monoclonal, Humanized - administration & dosage | Complement Inactivating Agents - economics | Adult | Female | Atypical Hemolytic Uremic Syndrome - diagnosis | Atypical Hemolytic Uremic Syndrome - drug therapy | Child | Complement Inactivating Agents - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Drug-Related Side Effects and Adverse Reactions - etiology | Treatment Outcome | Withholding Treatment | Remission Induction | Urinalysis - methods | Atypical Hemolytic Uremic Syndrome - physiopathology | Adolescent | Hemoglobinuria - etiology | Monitoring, Physiologic - methods | Quality of Life | Complement Inactivating Agents - adverse effects | Hemoglobinuria - diagnosis | Drug-Related Side Effects and Adverse Reactions - classification
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
by Goodship, T.H and Cook, H.T and Fakhouri, F and Fervenza, F.C and Fremeaux-Bacchi, V and Kavanagh, D and Nester, C.M and Noris, M and Pickering, M.C and Cordoba, S and Roumenina, L.T and Sethi, S and Smith, R.J and Kar, N.C. van de and et al and Conf Participants and Conference Participants
Kidney International. Supplement, ISSN 0085-2538, 2017, Volume 91, Issue 3, pp. 539 - 551
In both atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G) complement plays a primary role in disease pathogenesis. Herein we report the... 
anti-complement therapies | MESANGIOCAPILLARY GLOMERULONEPHRITIS | C3 glomerulopathy | kidney disease | MACULAR DEGENERATION | RENAL-TRANSPLANTATION | atypical hemolytic uremic syndrome | COMPLEMENT FACTOR-H | ALTERNATIVE PATHWAY | OXFORD CLASSIFICATION | UROLOGY & NEPHROLOGY | ECULIZUMAB MAINTENANCE TREATMENT | IGA NEPHROPATHY | complement | glomerulonephritis | MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS | DENSE-DEPOSIT DISEASE | Genetic Predisposition to Disease | Kidney - drug effects | Kidney - pathology | Humans | Risk Factors | Glomerulonephritis - genetics | Kidney - immunology | Glomerulonephritis - immunology | Treatment Outcome | Atypical Hemolytic Uremic Syndrome - immunology | Complement C3 - immunology | Glomerulonephritis - drug therapy | Atypical Hemolytic Uremic Syndrome - pathology | Phenotype | Animals | Glomerulonephritis - pathology | Complement Inactivating Agents - therapeutic use | Atypical Hemolytic Uremic Syndrome - drug therapy | Atypical Hemolytic Uremic Syndrome - genetics | Complement C3 - genetics | Complement Activation - drug effects | Life Sciences | Human health and pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Case studies in neurological pain
by Sommer, C
2012, Cambridge medicine, ISBN 0521695260, 152
Pain is one of the most common symptoms of neurological disease and its appropriate management is essential to the effective care of patients. Neurological... 
Other branches of medicine | Neuralgia | Nervous system | Diseases
Book
Details down arrow
5. Ductal carcinoma in situ of the breast
by Silverstein, Melvin J
1997, ISBN 9780683182446, xix, 665 p., [4] p. of plates
Breast | Cancer
Book
Details down arrow
6. Exceptional children in a modern society
by Love, Harold D
1967, 171
Exceptional children
Book
Details down arrow
7. Full Text The Priority position paper: Protecting Europe's food chain from prions
by Requena, Jesús R and Requena, Jesús R and Kristensson, Krister and Korth, Carsten and Zurzolo, Chiara and Simmons, Marion and Aguilar-Calvo, Patricia and Aguzzi, Adriano and Andreoletti, Olivier and Benestad, Sylvie L and Böhm, Reinhard and Brown, Karen and Calgua, Byron and del Río, José Antonio and Espinosa, Juan Carlos and Girones, Rosina and Godsave, Sue and Hoelzle, Ludwig E and Knittler, Michael R and Kuhn, Franziska and Legname, Giuseppe and Laeven, Paul and Mabbott, Neil and Mabbott, Neil and Mitrova, Eva and Müller-Schiffmann, Andreas and Nuvolone, Mario and Peters, Peter J and Raeber, Alex and Roth, Klaus and Schmitz, Matthias and Schroeder, Björn and Sonati, Tiziana and Stitz, Lothar and Taraboulos, Albert and Torres, Juan María and Yan, Zheng-Xin and Zerr, Inga
Prion, ISSN 1933-6896, 05/2016, Volume 10, Issue 3, pp. 165 - 181
Bovine spongiform encephalopathy (BSE) created a global European crisis in the 1980s and 90s, with very serious health and economic implications. Classical BSE... 
atypical BSE | prion | atypical scrapie | CJD | BSE | scrapie | PROTEIN | PEYERS-PATCHES | BIOCHEMISTRY & MOLECULAR BIOLOGY | VARIANT | SCRAPIE AGENT NEUROINVASION | BOVINE SPONGIFORM ENCEPHALOPATHY | TUNNELING NANOTUBES | FOLLICULAR DENDRITIC CELLS | BLOOD-TRANSFUSION | CREUTZFELDT-JAKOB-DISEASE | Prions - metabolism | Scrapie - diagnosis | Scrapie - prevention & control | Prions - pathogenicity | Humans | Encephalopathy, Bovine Spongiform - transmission | Europe - epidemiology | Prions - analysis | Encephalopathy, Bovine Spongiform - diagnosis | Encephalopathy, Bovine Spongiform - epidemiology | Food Chain | Animals | Prion Diseases - transmission | Cattle | Prions - isolation & purification | Scrapie - transmission | Encephalopathy, Bovine Spongiform - prevention & control | Prion Diseases - diagnosis | Prion Diseases - epidemiology | Early Diagnosis | Prion Diseases - prevention & control | Animal Feed - adverse effects | Scrapie - epidemiology | Life Sciences | Cellular Biology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text HUS and atypical HUS
by Sakari Jokiranta, T
Blood, ISSN 0006-4971, 05/2017, Volume 129, Issue 21, pp. 2847 - 2856
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy characterized by intravascular hemolysis, thrombocytopenia, and acute kidney failure. HUS is... 
SYSTEMIC-LUPUS-ERYTHEMATOSUS | TISSUE FACTOR ACTIVITY | HEMOLYTIC-UREMIC SYNDROME | CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME | ENDOTHELIAL-CELLS | FACTOR-H | THROMBOTIC THROMBOCYTOPENIC PURPURA | PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA | SHIGA-TOXIN | HEMATOLOGY | ALTERNATIVE COMPLEMENT PATHWAY | Hemolysis | Atypical Hemolytic Uremic Syndrome - therapy | Endothelial Cells - metabolism | Humans | Vitamin B 12 - blood | Diacylglycerol Kinase - genetics | Atypical Hemolytic Uremic Syndrome - pathology | Complement Activation - genetics | Thrombosis - pathology | Diacylglycerol Kinase - blood | Platelet Activation | Thrombosis - genetics | Thrombosis - blood | Endothelial Cells - pathology | Atypical Hemolytic Uremic Syndrome - genetics | Thrombosis - therapy | Atypical Hemolytic Uremic Syndrome - blood | 100 | 101 | Review Series | Clinical Platelet Disorders
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Effective treatment of chemotherapy induced atypical Haemolytic Uraemic Syndrome: a case series of 7 treated patients
by Weitz, Ilene C and Deloughery, Thomas
British Journal of Haematology, ISSN 0007-1048, 10/2018, Volume 183, Issue 1, pp. 136 - 139
chemotherapy | atypical haemolytic uraemic syndrome | eculizumab | HEMATOLOGY | INDUCED THROMBOTIC MICROANGIOPATHY | Endothelium - pathology | Antibodies, Monoclonal, Humanized - therapeutic use | Atypical Hemolytic Uremic Syndrome - chemically induced | Humans | Middle Aged | Endothelium - injuries | Atypical Hemolytic Uremic Syndrome - etiology | Male | Treatment Outcome | Atypical Hemolytic Uremic Syndrome - pathology | Young Adult | Antibodies, Monoclonal, Humanized - administration & dosage | Antineoplastic Agents - adverse effects | Adult | Female | Aged | Atypical Hemolytic Uremic Syndrome - drug therapy | Complement C5 - antagonists & inhibitors | Chemotherapy | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
by Vannucchi, A.M and Barbui, T and Cervantes, F and Harrison, C and Kiladjian, J.-J and Kröger, N and Thiele, J and Buske, C and ESMO Guidelines Comm and ESMO Guidelines Committee
Annals of Oncology, ISSN 0923-7534, 09/2015, Volume 26, Issue suppl 5, pp. v85 - v99
PROGNOSTIC SCORING SYSTEM | IWG-MRT | POLYCYTHEMIA-VERA | RISK ESSENTIAL THROMBOCYTHEMIA | ONCOLOGY | REVISED RESPONSE CRITERIA | POST-ESSENTIAL THROMBOCYTHEMIA | ACUTE MYELOID-LEUKEMIA | STEM-CELL TRANSPLANTATION | PRIMARY MYELOFIBROSIS | INTERNATIONAL WORKING GROUP | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative - pathology | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative - diagnosis | Philadelphia Chromosome | Humans | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative - therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Atypical aHUS: State of the art
by Nester, Carla M and Barbour, Thomas and de Cordoba, Santiago Rodriquez and Dragon-Durey, Marie Agnes and Fremeaux-Bacchi, Veronique and Goodship, Tim H.J and Kavanagh, David and Noris, Marina and Pickering, Matthew and Sanchez-Corral, Pilar and Skerka, Christine and Zipfel, Peter and Smith, Richard J.H
Molecular Immunology, ISSN 0161-5890, 09/2015, Volume 67, Issue 1, pp. 31 - 42
Tremendous advances in our understanding of the thrombotic microangiopathies (TMAs) have revealed distinct disease mechanisms within this heterogeneous group... 
ECULIZUMAB THERAPY | COMPLEMENT FACTOR-H | SYSTEMIC-LUPUS-ERYTHEMATOSUS | HEMOLYTIC-UREMIC SYNDROME | COBALAMIN-C DISEASE | BONE-MARROW-TRANSPLANTATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | THROMBOTIC THROMBOCYTOPENIC PURPURA | IMMUNOLOGY | STEM-CELL TRANSPLANTATION | MEMBRANE COFACTOR PROTEIN | VON-WILLEBRAND-FACTOR | Communicable Diseases - pathology | Kidney Neoplasms - genetics | Complement Activation | Kidney - pathology | Humans | Kidney - immunology | Kidney Neoplasms - immunology | Complement C3b Inactivator Proteins - genetics | Atypical Hemolytic Uremic Syndrome - etiology | Communicable Diseases - genetics | Atypical Hemolytic Uremic Syndrome - immunology | Autoantibodies - biosynthesis | Adult | Kidney Neoplasms - complications | Atypical Hemolytic Uremic Syndrome - genetics | Child | Complement Factor H - immunology | Genetic Predisposition to Disease | Gene Expression Regulation - immunology | Kidney Transplantation | Atypical Hemolytic Uremic Syndrome - pathology | Communicable Diseases - immunology | Complement C3b - genetics | Kidney Neoplasms - pathology | Complement Factor H - genetics | Communicable Diseases - complications | Complement C3b - immunology | Complement C3b Inactivator Proteins - immunology | Monoclonal antibodies | Medical colleges | Anemia | Mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Treatment outcomes of 17 patients with atypical spinal meningioma, including 4 with metastases: a retrospective observational study
by Noh, Sung Hyun and Kim, Kyung Hyun and Kim, Keung Nyun and Kim, Keun Su and Shin, Dong Ah and Park, Jeong Yoon and Yi, Seong and Kuh, Sung Uk and Chin, Dong Kyu and Yoon, Do Heum and Cho, Yong Eun
The Spine Journal, ISSN 1529-9430, 02/2019, Volume 19, Issue 2, pp. 276 - 284
Because of the scarcity of atypical spinal meningioma, there is a lack of research on this type of tumor or its associated metastases. The aim of this study... 
Atypical meningioma Atypical spinal meningioma | Spinal cord | Complete resection Metastasis | Adjuvant therapy | SURGERY | Complete resection | Atypical spinal meningioma | Atypical meningioma | Metastasis | ORTHOPEDICS | PROGRESSION | CLINICAL NEUROLOGY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text The new genetics of chronic neutrophilic leukemia and atypical CML: Implications for diagnosis and treatment
by Gotlib, Jason and Maxson, Julia E and George, Tracy I and Tyner, Jeffrey W
Blood, ISSN 0006-4971, 09/2013, Volume 122, Issue 10, pp. 1707 - 1711
Although activation of tyrosine kinase pathways is a shared theme among myeloproliferative neoplasms, the pathogenetic basis of chronic neutrophilic leukemia... 
COLONY-STIMULATING-FACTOR | FACTOR-RECEPTOR | CSF3R MUTATIONS | ACTIVATION | SEVERE CONGENITAL NEUTROPENIA | DISEASE | MYELODYSPLASTIC-SYNDROMES | IDENTIFICATION | HEMATOLOGY | CHRONIC MYELOID-LEUKEMIA | CHRONIC MYELOMONOCYTIC LEUKEMIA | Leukemia, Neutrophilic, Chronic - diagnosis | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative - diagnosis | Leukemia, Neutrophilic, Chronic - therapy | Humans | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative - genetics | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative - pathology | Leukemia, Neutrophilic, Chronic - pathology | Receptors, Granulocyte Colony-Stimulating Factor - genetics | Leukemia, Neutrophilic, Chronic - genetics | Mutation - genetics | Nuclear Proteins - genetics | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative - therapy | Spotlight
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights